S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Edap Tms Stock Forecast, Price & News

-0.20 (-2.94%)
(As of 07/1/2022 03:57 PM ET)
Today's Range
50-Day Range
52-Week Range
529 shs
Average Volume
30,496 shs
Market Capitalization
$220.90 million
P/E Ratio
Dividend Yield
Price Target

Edap Tms MarketRank™ Forecast

Analyst Rating
3.00 Rating Score
61.6% Upside
$10.67 Price Target
Short Interest
0.06% of Float Sold Short
Dividend Strength
News Sentiment
1.60mentions of Edap Tms in the last 14 days
Based on 3 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.08) to ($0.04) Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

1.91 out of 5 stars

Medical Sector

611th out of 1,428 stocks

Electromedical Equipment Industry

9th out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive EDAP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edap Tms and its competitors with MarketBeat's FREE daily newsletter.

Edap Tms logo

About Edap Tms (NASDAQ:EDAP) Stock

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

EDAP Stock News Headlines

EDAP Reports First Quarter 2022 Results
EDAP TMS S.A. Q1 2022 Earnings Preview
EDAP TMS S.A. Q4 2021 Earnings Preview
EDAP TMS (NASDAQ:EDAP) Seems To Use Debt Rather Sparingly
See More Headlines

Industry, Sector and Symbol

Electromedical equipment
Current Symbol
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$51.94 million
Cash Flow
$0.09 per share
Book Value
$1.77 per share


Free Float
Market Cap
$220.90 million

Social Links

Edap Tms Frequently Asked Questions

Should I buy or sell Edap Tms stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Edap Tms stock.
View analyst ratings for Edap Tms
or view top-rated stocks.

What is Edap Tms' stock price forecast for 2022?

2 brokers have issued 1 year target prices for Edap Tms' shares. Their EDAP stock forecasts range from $10.00 to $11.00. On average, they predict Edap Tms' stock price to reach $10.67 in the next year. This suggests a possible upside of 61.6% from the stock's current price.
View analysts' price targets for Edap Tms
or view top-rated stocks among Wall Street analysts.

How has Edap Tms' stock performed in 2022?

Edap Tms' stock was trading at $5.99 at the start of the year. Since then, EDAP stock has increased by 10.2% and is now trading at $6.60.
View the best growth stocks for 2022 here

When is Edap Tms' next earnings date?

Edap Tms is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022.
View our earnings forecast for Edap Tms

How were Edap Tms' earnings last quarter?

Edap Tms S.A. (NASDAQ:EDAP) announced its quarterly earnings data on Tuesday, May, 17th. The medical equipment provider reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.02. The medical equipment provider earned $14.53 million during the quarter, compared to the consensus estimate of $12.96 million. Edap Tms had a trailing twelve-month return on equity of 0.44% and a net margin of 0.47%. During the same quarter in the prior year, the firm earned $0.03 EPS.
View Edap Tms' earnings history

Who are Edap Tms' key executives?

Edap Tms' management team includes the following people:
  • Mr. Marc Oczachowski, Exec. Chairman & CEO (Age 52)
  • Mr. Francois Dietsch, Chief Financial Officer (Age 46)
  • Mr. Frederic Pech, Chief Operating Officer
  • Ms. Blandine Confort, Investor Relations Officer & Sec.
  • Mr. Frank Van Hyfte, VP of Global Sales & Marketing

What other stocks do shareholders of Edap Tms own?

What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

How do I buy shares of Edap Tms?

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $6.60.

How much money does Edap Tms make?

Edap Tms (NASDAQ:EDAP) has a market capitalization of $220.90 million and generates $51.94 million in revenue each year. The medical equipment provider earns $830,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis.

How many employees does Edap Tms have?

Edap Tms employs 223 workers across the globe.

When was Edap Tms founded?

Edap Tms was founded in 1979.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The official website for Edap Tms is www.edap-tms.com. The medical equipment provider can be reached via phone at (347) 215-3150, via email at bconfort@edap-tms.com, or via fax at 33-04-72-15-31-51.

This page (NASDAQ:EDAP) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.